4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Nyxoah SA (NYXH) operates in the Medical Instruments & Supplies industry and is headquartered in Mont-Saint-Guibert, Belgium with about 153 employees. Its market capitalization is roughly $167 million. In the fiscal year ended 2025-12-31, NYXH reported $10M in revenue and ($90M) in net income.
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea.
Interactive charts & full statements → Open the NYXH valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $10M | $4M | $4M | $3M |
| Gross Profit | $6M | $3M | $3M | $2M |
| Operating Income (EBIT) | ($83M) | ($59M) | ($45M) | ($32M) |
| Net Income | ($90M) | ($59M) | ($43M) | ($31M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $6M | $6M | $2M | $1M | $1M |
| Gross Profit | $4M | $4M | $1M | $1M | $1M |
| Operating Income (EBIT) | ($20M) | ($18M) | ($24M) | ($20M) | ($21M) |
| Net Income | ($16M) | ($24M) | ($24M) | ($21M) | ($22M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | $0M | $0M | $0M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $118M | $158M | $124M | $146M | — |
| Total Liabilities | $69M | $45M | $26M | $26M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NYXH viewer.
About TickerBase · Data methodology & sources